Shionogi Of Japan Cancels Plan To Buy Victory Pharma Of U.S.
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi says it is bailing out of a proposal to buy U.S.-based Victory Pharma for $150 million. The company issued a statement saying it was canceling its plan because the deal had encountered "a situation" that had not been anticipated at the time of the agreement. The Shionogi statement did not elaborate. The deal had been made through Shionogi's U.S. subsidiary, Sciele Pharma. (Click here for more